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ABSTRACT
Objective. To compare the induction of the aggrecanases (ADAMTS 1, 4, 5, 8, 
9 and 15) by interleukin-1 (IL-1) and tumor necrosis factor- (TNF-) in 
chondrocyte-like OUMS-27 cells and human chondrocytes and to determine the 
mechanism of induction of the most responsive aggrecanase gene.
Methods. OUMS-27 cells were stimulated for different periods of time and 
concentrations of IL-1 and/or TNF-.   Human chondrocytes obtained from 
osteoarthritic joints and human skin fibroblasts were also stimulated with IL-1 and/or
TNF-.   Total RNA was extracted, reverse transcribed, and analyzed by quantitative 
real-time polymerase chain reaction and Northern blotting.   ADAMTS9 protein was 
examined by Western blotting and the role of the MAPK signaling pathway for 
ADAMTS9 induction in IL-1 stimulated OUMS-27 cells was investigated.
Results. IL-1 increased mRNA levels of ADAMTS4, ADAMTS5 and 
ADAMTS9, but not ADAMTS1 and ADAMTS8. ADAMTS9 mRNA fold-increase was 
greater than for the other aggrecanase mRNAs. The increase of ADAMTS9 mRNA by 
IL-1stimulation was greater in chondrocytes than in fibroblasts.  The combination of 
IL-1 and TNF- had a synergistic effect resulting in considerable elevation of
ADAMTS9 mRNA. ADAMTS9 protein was also induced in IL-1stimulated 
OUMS-27 cells. MAPK inhibitors, SB203580 and PD98059, decreased ADAMTS9 
upregulation in OUMS-27 cells.   
Conclusion. ADAMTS9 is an IL-1 and TNF- inducible gene that appears to 
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be more responsive to these pro-inflammatory cytokines than other aggrecanase genes.  
Furthermore, these cytokines had a synergistic effect on ADAMTS9. Together with its 
known ability to proteolytically degrade aggrecan, and its potential to cleave other 
cartilage molecules, the data suggest that ADAMTS9 may have a pathological role in 
arthritis.
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Introduction
Articular cartilage is a highly specialized tissue that covers the bony surface in 
the synovial joints, allowing smooth lubrication and providing resistance to joint forces. 
Cartilage matrix is synthesized and maintained by chondrocytes, and some of its 
constituents are the collagens II, IX, and XI, aggrecan, perlecan, COMP and others.
Aggrecan, a large aggregating proteoglycan, forms a macromolecular complex with 
hyaluronan and link protein. It swells within the interstices of the collagen framework 
and provides compressibility to cartilage (1, 2).
Proteolytic degradation of articular cartilage is a key feature of arthritic joint 
destruction.   The loss of aggrecan is considered to be a critical early event of cartilage 
destruction, occurring initially at the joint surface and progressing to the deeper zones. 
This step is followed by degradation of collagen fibrils and mechanical failure of the 
tissue (2). The degradation of cartilage is mediated by a number of different proteases, 
including neutral endopeptidases of the metalloproteinase superfamily of enzymes. 
Members of two metalloproteinase families, matrix metalloproteinase (MMP) and 
ADAMTS, have been implicated in cartilage matrix destruction (1). 
The ADAMTS (A disintegrin-like and metalloproteinase domain (reprolysin 
type) with thrombospondin type 1 motifs) family contains 19 individual gene products 
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(3). Certain members of the ADAMTS family (ADAMTS1, ADAMTS4, ADAMTS5, 
ADAMTS8, ADAMTS9 and ADAMTS15) are called ‘aggrecanases’, and they can 
proteolytically process aggrecan within the interglobular domain separating its globular 
G1 and G2 of domains at a specific Glu373-Ala374 bond (3-5) or at one or more sites 
within the more C-terminal glycosaminoglycan-bearing region (6). Proteolytic 
liberation of the GAG-bearing regions reduces the load bearing properties of articular 
cartilage and may accompany or initiate a series of cellular responses that culminate in 
loss of joint cartilage. These proteases are believed to be active both in inflammatory 
arthritis and osteoarthritis.
Aggrecanase activity was first detected in bovine articular cartilage treated with 
IL-1, but it is also enhanced by TNF- or retinoic acid (7, 8). These data support the 
hypothesis that aggrecanases are active early in the disease process of arthritis, or in 
acute inflammatory episodes. However, the exact enzyme(s) responsible for cartilage 
aggrecan degradation both during active inflammation and as arthritis progresses are 
still unclear (9). ADAMTS4 (aggrecanase-1), ADAMTS5 (aggrecanase-2) and 
subsequently, ADAMTS1, were the first proteases to which significant aggrecanase 
activity was attributed (4-6), although their specific importance in the context of 
arthritis is not yet fully established.  Like ADAMTS4 and ADAMTS1, ADAMTS9, 
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and more recently ADAMTS8 and ADAMTS15 were shown to be aggrecanases (10-12). 
ADAMTS9 was expressed in OA in gene profiling studies (9, 13).  These experimental 
studies, observations from phylogeny of the ADAMTS proteases (3, 11) and absence of 
aggrecanase activity in numerous other ADAMTS proteases suggests that the enzymes 
examined in this study include the complete set of ADAMTS aggrecanases. To further 
investigate the significance of each of these, it would be important to study their
expression and cytokine induction in chondrocytes.
Since normal articular cartilage is relatively acellular and difficult to obtain, we 
have instead used in these studies, OUMS-27, a recently established cell line with 
chondrocytic properties (14).   The effects of two major proinflammatory cytokines, 
IL-1 and TNF-, were investigated to ask how and which aggrecanase may play a role 
in inflammatory disease of cartilage
MATERIALS AND METHODS 
Reagents 
Recombinant human IL-1 and TNF- were purchased from R&D Systems 
(Minneapolis, MN, USA).   The cytokines were stored at –80 °C and diluted in culture 
medium immediately prior to use. Antibodies to phosphorylated MAPKs were 
purchased from Cell Signaling Technology (Beverly, MA, USA). The p44/42 MAPK 
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inhibitor PD 98059 and p38 MAPK inhibitor SB 203580 were purchased from 
Calbiochem (San Diego, CA, USA) and dissolved in dimethyl sulfoxide (DMSO).  All 
other chemicals and biochemicals were from Sigma (St. Louis, MO, USA).  
Cell culture
OUMS-27 cells were a kind gift from Dr. T. Kunisada (Okayama University 
Graduate School of Medicine and Dentistry, Okayama, Japan). OUMS-27 cells were 
cultured in Dulbecco's modified Eagle's medium (DMEM) containing 10 % fetal bovine 
serum (FBS) and penicillin/streptomycin at 37 °C in a humidified atmosphere of 5 % 
CO2 in air.   The cells were subcultured at split ratios of 1:2 to 1:4 using trypsin + 
EDTA every 7 to 10 days. The medium was changed every 3 days. Cells were 
used at passages 7 to 14 for all experiments.   For most experiments, 5 x 105 cells were 
plated in 60-mm dishes and transferred to serum-free DMEM for 24 hr and then 
exposed to the different cytokines and inhibitors at the concentrations and times 
indicated.
Human articular chondrocytes (Cryo NHAC-kn) were purchased from Sanko 
Junyaku (Tokyo, Japan) and cultures were maintained according to the manufacturer's 
protocol.  Chondrocytes between passages 3 - 7 were used for the analysis.  Human 
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skin fibroblast cells (HSF) were kindly provided from Dr. S. Hattori (Nippi Research 
Institute of Biomatrix, Tokyo, Japan).  HSF are cultured as previously described (15).   
Generation of ADAMTS9 antibody
A synthetic peptide CQHPFQNEDYRPRSASPSRTH derived from the human 
ADAMTS9 amino acid sequence (13) was synthesized at the NIH-supported Lerner 
Research Institute Biotechnology core, congulated to keyhole limpet hemocyanin and 
used as an immunogen in rabbits to generate polyclonal antisera (Alpha Diagnostics 
International, Houston, TX). The antiserum was affinity-purified against the 
immobilized peptide immunogen. It was tested by western blot analysis of 
HEK293F cells stably transfected with full-length ADAMTS9. Lysate and 
conditioned medium of stably transfected cells, but not untransfected cells, 
demonstrated a reactive band of ~180-200 kDa on denaturing SDS-PAGE, which is 
compatible with the predicted molecular mass of ADAMTS9. Other bands of 100 
and 75 kDa were identified in untransfected 293 cells and are believed to represent 
cross-reactivity with proteins other than ADAMTS9.
Cytokine stimulation and protein kinase inhibitor assay
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All cells were first incubated in 4 ml of medium containing 10 % FBS. After 
72 hr, the medium was changed to serum-free DMEM and the cells were incubated for 
another 24 hr. The cells were then exposed to various concentrations of IL-1 (10 to 
100 ng/ml) and/or TNF- (5 to 50 ng/ml) in phosphate buffered saline (PBS), or PBS 
containing 0.1 % BSA as a control (n=4 each) following the protocol previously
reported (16, 17). 
For kinase assays, cells were cultured on 60-mm dishes and serum-starved for 
24 hr before stimulation. OUMS-27 cells were pretreated with 10-100 µM PD 98059, a 
specific inhibitor of p44/42 kinase, or 5-50 µM SB 203580, a specific inhibitor of p38 
kinase, or DMSO alone (as a vehicle control) for 30 min and subsequently incubated 
with IL-1 (10 ng/ml).  
RNA preparation and reverse transcription - polymerase chain reaction (RT-PCR)
Following stimulation, the cells were washed once with PBS and total RNA was 
extracted using TRIzol according to the manufacturer’s instructions. Residual DNA 
was removed by treatment with 5 units of DNase I (Roche Diagnostics Ltd, Lewes, UK) 
at room temperature for 15 min followed by inactivation at 65 °C for 10 min.  Two 
micrograms of total RNA was reverse-transcribed to cDNA with random primers 
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according to the manufacturer’s protocol (Toyobo, Osaka, Japan).    Primers for PCR 
were designed to amplify 90-700 bp fragments for each gene (ADAMTS1, ADAMTS4, 
ADAMTS5, ADAMTS8, ADAMTS9, ADAMTS15, 1 type II collagen (COL2A1), 
COL9A1, aggrecan and -actin) (Table I). RT-PCR was performed for 35 cycle 
(except -actin, 25 cycle) of incubation at 94 °C for 30 sec, at 60 °C for 30 sec, and at 
72 °C for 30 sec, and the final incubation at 72 °C for 7 min, with slight modification to 
optimize the annealing conditions for each gene.
Quantitative real-time RT-PCR
Quantitative real-time RT-PCR analysis was performed using a LightCycler 
rapid thermal cycler system (Roche Diagnostics Ltd) following the protocol previously 
reported (18, 19). The PCR mixture consisted of 1X SYBR Green PCR Master Mix, 
which includes DNA polymerase, SYBR Green I Dye, dNTPs including dUTP, PCR 
buffer, 10 pmol forward and reverse primers, and cDNA of samples in a total volume of 
20 µl.    The amplification of a housekeeping gene, -actin, was used for normalizing 
the efficiency of cDNA synthesis and the amount of RNA applied.   To validate the 
specificity of amplification of ADAMTSs and -actin, we analyzed each PCR product by 
agarose gel electrophoresis after real-time detection. Each sample was amplified in
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triplicate or duplicate. Negative controls were performed with samples in which the 
RNA templates were replaced by nuclease-free water in the reactions.   The intra- and 
interassay coefficients of variations were <5 % and were reasonably small compared 
with those in other reports. Subsequently, the threshold cycle (Ct), i.e., the number of 
cycles at which the amount of the amplified gene of interest reached a fixed threshold,
was determined. 
Northern blot analysis
Northern blot analysis was performed as previously reported (19, 20).  Total
RNA was electrophoresed on a 1 % agarose gel, blotted onto Hybond NX nylon 
membrane (Amersham Pharmacia Biotech, Buckinghamshire, UK) and hybridized with 
32P-dCTP radiolabeled probes (Amersham Pharmacia Biotech).   The mouse 
aggrecan (NM_007424) cDNA fragment was cloned between the NotI and EcoRI sites 
of vector pT7T3D and used for Northern blot analysis.   The ADAMTS9 probe was a 
960-bp fragment of mouse ADAMTS9 cDNA, as previously reported (13).  The 
ADAMTS5 probe used for the Northern blot analysis was amplified by RT-PCR 
(182-bp) and subcloned into TA cloning vector, as previously reported (21).   
Hybridization was carried out at 65 °C overnight in Church buffer.  The membrane 
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was washed and then exposed to X-ray film (Kodak, Tokyo, Japan) with an intensifying 
screen.  The radiolabeled bands were densitometrically quantified using a BAS image 
analyzing system (Fuji Film, Tokyo, Japan).
Protein extraction
Cells were incubated with or without cytokines in the medium as previously 
reported (22, 23).  After stimulation, the cells were washed once with PBS and then 
scraped from the culture dish. Cell pellets were solubilized in 400 µl of cell lysis 
buffer (Sigma) with a complete protease inhibitor cocktail (Sigma). For phosphorylation 
analysis, cells were washed with PBS and lysed in buffer containing 1 mM Na3VO4, 
1 mM PMSF, 1 mM Na-F and complete protease inhibitor cocktail. After incubation in 
a rotator at 4 °C for 15 min, the samples were centrifuged and, the supernatants were 
collected.  The protein concentration of the cell extracts was determined by using a 
protein assay kit (Bio-Rad, Hercules, CA, USA).
Western blot analysis
Cell lysates (15 µg of total protein/lane) were subjected to sodium dodecyl 
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) using a 4-12 % gradient gel 
and then transferred onto nitrocellulose membranes (Advantech, Tokyo, Japan).
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Membranes were blocked with 5 % skim milk and 0.05 % Triton X-100 in PBS
(PBS-T), and then incubated with primary antibody in PBS-T for overnight.
Membranes were washed with PBS-T and then incubated with the appropriate 
HRP-conjugated secondary antibody diluted in blocking buffer. Immunoreactive 
proteins were detected using the enhanced chemiluminescence system (Amersham 
Pharmacia Biotech).  To examine the regulation of ADAMTS9 protein expression by 
IL-1, chondrosarcoma cells were incubated with medium in either the presence or 
absence of IL-1 (10 ng/ml).   Protein expression in cell lysates was determined by 
Western blot analysis.   
Statistical analysis
Data are expressed as the mean value ±SD.   Statistical comparisons of means 
were performed by analysis of variance (ANOVA) followed by paired-Student t-test.    
A P-value of <0.05 was considered statistically significant.
RESULTS
The expression of cartilage specific ECM genes and ADAMTS genes in OUMS-27 
cells
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Initial experiments were performed to determine the mRNA expression of 
cartilage-specific proteoglycan (i.e., aggrecan) and other ECM genes in cultured 
OUMS-27 cells by RT-PCR.   The cDNAs were prepared from unstimulated cultured 
OUMS-27 cells and amplified with specific primers for aggrecan, COL2A1, COL9A1 or
-actin (Table I). The PCR products were separated by electrophoresis on an agarose 
gel and specific bands corresponding to each gene product (COL2A1, 621bp; COL9A1,
159bp; aggrecan, 501bp;) were observed (Figure 1A).   
Then we examined whether the expression level of aggrecan mRNA was altered 
by IL-1 in OUMS-27 cells. As previously reported in bovine and human 
chondrocytes (16, 24), IL-1 attenuated the expression of the aggrecan gene in 
OUMS-27 cells in a time-dependent manner (Fig. 1B).   These data indicate that 
despite being cancer cells, OUMS-27 cells retain their chondrocytic phenotype at least 
to a certain degree.
Next, to ask whether the ADAMTS genes were expressed in cultured OUMS-27 
cells under basal conditions, we amplified the cDNAs from unstimulated OUMS-27 
cells by using ADAMTS specific primers. The PCR products were separated by 
electrophoresis on an agarose gel and specific bands corresponding to each gene product 
(ADAMTS1, 90 bp; ADAMTS4, 241 bp; ADAMTS5, 182 bp; ADAMTS8, 194 bp; 
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ADAMTS9, 303 bp; ADAMTS15, 183 bp;) were observed in all instances except for 
ADAMTS8 (Fig. 1C).   
Time course of aggrecanase expression after IL-1 stimulation
OUMS-27 cells were cultured in the presence of IL-1 (10 ng/ml), and total 
RNA was extracted at 3, 6, 12, 24, and 48 hr.  The relative levels of individual 
aggrecanase gene mRNA expression were determined by quantitative real-time RT-PCR 
and compared with those of unstimulated cells (n=3 independent experiments).  The 
polygonal-to-round chondrocytic shape was maintained in OUMS-27 cells during the 
stimulation (Fig. 2A).   As shown in Fig. 2B, ADAMTS1 mRNA expression was not 
increased, but rather decreased, by IL1- stimulation.   IL1- increased the 
aggrecanase-1 (ADAMTS4) mRNA expression level; the increase was first noted at 6 hr, 
and it reached a maximum at 12 hr, following which it declined.   The aggrecanase-2 
(ADAMTS5) mRNA expression level also reached a peak at 12 hr and decreased at 48 hr. 
The ADAMTS9 mRNA expression levels peaked at 6 hr and then gradually decreased.   
ADAMTS9 was increased 13.3-fold compared at 6 hr with that of unstimulated cells.   
ANOVA revealed that this elevation was significant (p<0.01). ADAMTS8 was not 
expressed in unstimulated OUMS-27 cells (Fig. 1C) or IL-1-stimulated OUMS-27 
cells (data not shown). 
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We then examined whether ADAMTS9 is induced in articular chondrocytes by 
IL-1 stimulation.   The rounded polygonal shape of chondrocytes was maintained in 
monolayer culture during the stimulation (data not shown).  As shown in Figure 2C, 
ADAMTS9 was significantly induced by IL-1 in chondrocytes with its peak at 6 hr.   
The induction of ADAMTS9 mRNA expression by IL-1 in chondrocytes occurred in a 
similar time-dependent manner as OUMS-27 cells.
ADAMTS9 expression in OUMS-27 cells
Because ADAMTS9 was the aggrecanase gene most highly expressed without 
stimulation and most highly inducible by IL1- in OUMS-27 cells, we further 
characterized mRNA expressions of ADAMTS9 as well as ADAMTS4 and ADAMTS5 by 
Northern blot analysis.  OUMS-27 cells were stimulated with IL1- (10 ng/ml) for 1, 3, 
6, 12, 24, 48, and 72 hr and compared with unstimulated controls (n=3, respectively).   
ADAMTS9 mRNA expression was first noted at 3 hr, and then further increased and 
reached a maximum at 6 hr, which was similar to that of human articular chondrocytes.  
ADAMTS9 then decreased toward the baseline level (Fig. 3A, top).  The expression 
level of ADAMTS4 was very low and the bands were not detected by Northern blot 
analysis (data not shown).  The positive band for ADAMTS5 was faintly detectable at 6 
hr and 12 hr and expression levels were much weaker than ADAMTS9 (Fig. 3A, 
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middle).    We next examined the ADAMTS9 protein production in IL-1 stimulated 
OUMS-27 cells.  Protein was extracted from cells with or without IL-1 stimulation 
(n=4, respectively) and Western blot analysis was performed using anti-ADAMTS9 
polyclonal antibody.   A strong band of around 180-200 kDa, which likely represents
an active form of ADAMTS9, was clearly observed as expected (Fig. 3B).   We were 
not able to detect ADAMTS9 protein in the OUMS-27 cell culture medium suggesting 
the secreted enzyme may be cell-anchored as previously described.
Cytokine induction of ADAMTS9 gene expression in OUMS-27 cells is 
dose-dependent
Next, the dose response of ADAMTS9 mRNA to IL-1 and TNF- stimulation 
was examined.  OUMS-27 cells were cultured in the presence of IL-1 (0 - 100 ng/ml) 
or TNF- (0 - 50 ng/ml) (n=3, respectively).   IL-1 caused dose-dependent induction 
of ADAMTS9 mRNA (Fig. 3C).  TNF- alone induced ADAMTS9 mRNA expression 
as well, as previously reported in retinal pigment epithelium cells (25), while TNF- did 
not show  a linear dose-dependent induction of ADAMTS9 in OUMS-27 cells (Fig. 
3D). 
Synergistic induction of ADAMTS9 mRNA expression in chondrosarcoma cells by 
the combination of IL1- and TNF-
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Synergistic induction of ADAMTS was examined in chondrosarcoma cells 
treated with the combination of IL-1 (10ng/ml) and TNF- (10ng/ml) at the 6 hr time 
point (Fig. 4A). ADAMTS9 mRNA expression was markedly upregulated 33–fold by the 
combination of IL-1 and TNF- at 6 hr.   We also compared the induction of
ADAMTS9 gene by the stimulation with IL-1 between chondrocytes and fibroblasts 
(Fig. 4B).  ADAMTS9 was induced both in the chondrocytes and HSF cells.  
Interestingly, the augmentation of the expression level of ADAMTS9 mRNA in 
chondrocytes was greater than that of HSF cells.  Furthermore, the induction pattern of 
ADAMTS9 by IL-1 and/or TNF- was different between these two cell lines.  That is, 
in chondrocytes, IL-1 augmented the expression level of ADAMTS9 mRNA more than 
TNF-, which was opposite in the case of HSF cells, and the synergistic effect of 
combination of IL-1 and TNF- was greater in chondrocytes than HSF cells (Fig. 4B).   
In contrast, ADAMTS4 mRNA expression appeared to be only moderately upregulated 
by IL-1 and TNF- and no induction of mRNA expression for ADAMTS5 was 
observed at 6 hr (data not shown).   
IL-1 stimulates phosphorylation of MAPKs in OUMS-27 cells
In chondrocytes, the activation of the signaling pathways of mitogen-activated 
protein kinases (MAPKs), including extracellular signal-regulated kinase (ERK) and 
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p38, by IL-1 stimulation was reported (26, 27). SB203580, a specific inhibitor p38, 
almost completely blocked the induction of MMP-13 by IL-1 stimulation (26), 
suggesting its crucial role for the induction of MMP-13 gene.   However, these 
pathways have not been examined in the case of chondrosarcoma cells and the 
relationship between these signaling pathways and ADAMTS induction has not been 
studied.  To investigate the molecular mechanism of the up-regulation of ADAMTS9 by 
IL-1, OUMS-27 cells were stimulated with IL-1 for 10 - 120 min and the time-course 
of phosphorylation of MAPKs, p38 and p44/42 were examined.   IL-1 immediately 
increased the phosphorylation of p38 by 10 min, and this increase was terminated by 60 
min (Fig. 5A).   Phosphorylation of p44/42 peaked at 10 min and then, declined to the 
control level at 30 min. (Fig. 6A).   Thus, IL-1 activates the p38 and p44/42 
pathways in IL-1-stimulated OUMS-27 cells.   To investigate the role of the p38 
pathway in IL-1 induced ADAMTS9 expression, OUMS-27 cells were pretreated with 
SB203580 or PD98059.   The effects of protein kinase inhibitors on ADAMTS9 
mRNA expression were measured by quantitative real-time RT-PCR at 6 hrs. There was 
no obvious cytotoxic effect to the OUMS-27 cells by using these protein kinase 
inhibitors during the study.   SB 203580 dose-dependently but only partially reduced 
the induction of ADAMTS9 mRNA (Fig. 6B).   PD98059 also caused the attenuation 
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of ADAMTS9 gene induction (Fig. 6C).  
DISCUSSION
   In this study, we sought to identify which ADAMTS-aggrecanases were 
responsive to cytokine induction representative of some of the complex inflammatory 
cascade of arthritis. We showed that ADAMTSs were differentially regulated and 
ADAMTS9 was the most highly-induced among the aggrecanase family genes in IL-1 
stimulated chondrosarcoma derived cells and isolated chondrocytes.   The induction of 
ADAMTS9 gene by cytokine stimulation was greater in OUMS-27 cells and in 
chondrocytes compared with that of fibroblasts.
The difficulty of studying inflammatory responses of cartilage is partly due to 
the lack of available chondrocyte cell lines.   OUMS-27 cells were originally isolated 
from a chondrosarcoma patient.  Although OUMS-27 cells are cancer cells, they 
maintain the chondrocytic phenotype.   For instance, OUMS-27 cells maintained the 
polygonal-to-round shape, which is the typical morphology of chondrocytes, throughout 
this study.  Furthermore, OUMS-27 cells expressed cartilage-specific proteoglycan (i.e. 
aggrecan) as well as type II and IX collagen genes, which are considered to be 
cartilage-specific collagens.  Aggrecan gene expression and its attenuation by IL-1
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stimulation, which is notably observed in IL-1-stimulated chondrocytes (24), was 
observed in OUMS-27 cells as well.  In addition, the induction pattern of ADAMTS9 
gene by cytokine stimulation was similar (e.g. kinetics and synergistic effect by IL-1
and TNF-) between OUMS-27 cells and chondrocytes.   The observation that 
OUMS-27 cells, like chondrocytes, clearly exhibited a synergistic effect of IL-1 and 
TNF- suggest that OUMS-27 cells may be suitable as a surrogate model for analysis of 
cartilage catabolism.   
In unstimulated chondrocytes, RT-PCR analysis and Northern blot analysis 
revealed that ADAMTS9 mRNA had a higher basal expression than ADAMTS4 and 
ADAMTS5 although no protein was detected. Rapid induction of ADAMTS9 mRNA 
and protein in IL-1 stimulated OUMS-27 cells was also observed, suggesting that his 
protease may be an important early effector of the inflammatory response. Previous 
reports demonstrated the synergistic induction by combination of IL-1 and oncostatin 
M for ADAMTS4 and ADAMTS5 genes (1).    Our results show for the first time that 
ADAMTS9 can be induced by IL-1 or TNF- alone, and further showed the synergistic 
induction by the combination of IL-1 and TNF-, indicating that ADAMTS9 is a 
cytokine-augmented gene in chondrocytes.   Together, our data and previous reports (1, 
28) suggest that aggrecanase genes are synergistically induced by cytokines/growth 
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factors, which is relevant to the complex extracellular mileau in arthritis.
Finally, we investigated the inhibitory effects of MAPK on the expression levels 
of ADAMTS9 mRNA.   SB203580 dose-dependently attenuated the induction of 
ADAMTS9 mRNA, with approximately 50% attenuation at the concentration of 5 µM. 
PD98059 also exhibited the attenuation of ADAMTS9 mRNA induction. Sylvester et al. 
reported that both SB203580 and PD98059 attenuated the induction of the ADAMTS4
gene in IL-17-stimulated bovine chondrocytes (29) and Westra et al. reported that RWJ 
67657, a p38 MAPK inhibitor, attenuated the induction of the ADAMTS4 gene in 
TNF- and/or IL-1 stimulated human rheumatoid synovial fibroblasts (30).   Our 
results further extend those observations, but in the context of ADAMTS9 we conclude 
that p38 and p44/42 MAPKs play a role in the regulation of some, but not all, responses 
to IL-1.  Recently, transcriptional factors AP-1 and NF-B were shown to be 
involved in the induction of MMP genes (27, 28).   Granet et al, reported that 
combination of TNF- and IL-1 enhanced expression and additional recruitment of 
activated AP-1 and NF-B (31, 32). The fact that ADAMTS9 gene was induced 
synergistically by combination of IL-1 and TNF- suggests involvement of AP-1 and 
NF-B in ADAMTS9 gene regulation. The induction of ADAMTS9 gene in chondrocytic 
cells and chondrocytes was greater than those in the fibroblasts under cytokine 
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stimulation.  These results emphasize that the induction of ADAMTS9 may be related 
to inflammation in the cartilage.
Because ADAMTS9 is a recently reported enzyme, there is no previous data on 
its gene regulation and function in arthritic cartilage and little known information about 
its basic biochemistry. ADAMTS9 is the largest human ADAMTS protease and is 
closely related to ADAMTS20. Both enzymes have a very complex structure that 
includes 15 thrombospondin type-1 repeats. These proteases are evolutionarily related 
to GON-1, a metalloprotease required for cell migration in C-elegans (33). 
ADAMTS9 is first processed at consensus furin-cleavage sites in the secretory pathway 
to remove the pro-domain and generate a 180 - 200 kDa active form. Subsequent to 
secretion of this form and presentation at the cell surface, it appears that ADAMTS9 
undergoes additional proteolytic processing at the C-terminus (Koo, B-H. Somerville, 
R.P.T. and Apte, S.S. unpublished data), although the precise cleavage sites and 
mechanisms have not yet been established. No substrates for ADAMTS9 have been 
identified other than the proteoglycans versican and aggrecan. 
In conclusion, our results showed that ADAMTS9 gene expression is strongly 
induced by cytokines in OUMS-27 cells as well as chondrocytes, suggesting its role in 
inflammatory arthritides. Future studies will address whether the induced secretion 
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plays a major role in degradation of aggrecan or other secreted cartilage molecules.
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TABLE I. The primers used for the PCR analysis.
ADAMTS1 forward 5’-GGACAGGTGCAAGCTCATCTG-3’
reverse 5’-TCTACAACCTTGGGCTGCAAA-3’
ADAMTS4 forward 5’-AGGCACTGGGCTACTACTAT-3’
reverse 5’-GGGATAGTGACCACATTGTT-3’
ADAMTS5 forward 5’-TATGACAAGTGCGGAGTATG-3’
reverse 5’-TTCAGGGCTAAATAGGCAGT-3’
ADAMTS8 forward 5’-ACCATGTGGTGGACTCGCCT-3’
reverse 5’-GTTCCCATCGTTCTGCACAC-3’
ADAMTS9 forward 5’-GGACAAGCGAAGGACATCC-3’
reverse 5’-ATCCATCCATAATGGCTTCC-3’
ADAMTS15 forward 5’-GTGGGGGAGACAATAAGAGC-3’
reverse 5’-GGTACTTGCCTTGGCTGTTC-3’
aggrecan forward 5’-AAACCACCTCTGCATTCCAC-3’
reverse 5’-CCTCTGTCTCCTTGCAGGTC-3’
COL2A1 forward 5’-AACTGGCAAGCAAGGAGACA-3’
reverse 5’-AGTTTCAGGTCTCTGCAGGT-3’
COL9A1 forward 5’-GTGTTGCTGGTGAAAAGGGT-3’
reverse 5’-GGGATCCCACTGGTCCTAAT -3’
-actin forward 5’-TTCCTGGGCATGGAGTCCT-3’
reverse 5’-AGGAGGAGCAATGATCTTGATC-3’
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Figure legends   
Figure 1.  OUMS-27 cells have chondrocytic properties.   (A) The expression of 
cartilage-specific extracellular matrix genes was examined by RT-PCR in cultured 
OUMS-27 cells. The PCR products are electrophoresed on a 1.2% agarose gel. 
Single specific bands corresponding to each gene product (COL2A1, 621bp; COL9A1,
159bp; aggrecan, 501bp; (-), negative control (i.e. H2O as template) are observed. 
-actin served as an internal control for each sample (lower panel). 100 bp molecular 
weight marker is indicated at the left of the panel.   (B) Aggrecan mRNA was 
decreased by IL-1 treatment.  A single band of approximately 7.3 kb corresponding to 
aggrecan mRNA is observed.   Northern blot analysis demonstrates a change in 
aggrecan mRNA expression level in cells stimulated with IL-1 (10 ng/ml) for various 
time periods. (C) Expression of ADAMTS genes in cultured OUMS-27 cells. The 
PCR products are electrophoresed on a 1.2% agarose gel. Single specific bands 
corresponding to each gene product (ADAMTS1, 90 bp; ADAMTS4, 241 bp; ADAMTS5, 
182 bp; ADAMTS8, 194 bp; ADAMTS9, 303 bp; ADAMTS15, 183 bp; (-), negative 
control) were observed. -actin served as an internal control for each sample (lower 
panel). 100 bp molecular weight marker is indicated at the left of the panel. Note that 
ADAMTS9 mRNA is strongly expressed in unstimulated OUMS-27 cells.
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Figure 2. (A) The polygonal-to-round chondrocytic shape is maintained in 
OUMS-27 cells during stimulation.   (B) Quantitative real-time RT-PCR analysis of 
the expression of ADAMTS genes  (ADAMTS1, ADAMTS4, ADAMTS5 and ADAMTS9) 
in IL-1stimulated OUMS-27 cells. OUMS-27 cells are treated for 0 - 48 hr with 
IL-1 (10 ng/ml). Data are expressed as the mean ± SD of three independent
experiments.  Note that the increase in the expression levels of ADAMTS9 mRNA is 
larger than those of other ADAMTS members in IL-1-stimulated samples. * Indicates 
P <0.05 compared to unstimulated cells. (C) Induction of ADAMTS9 mRNA by IL-1 in 
chondrocytes.  Human chondrocytes were cultured in the presence of IL-1 for 0 - 24 
hr and ADAMTS9 mRNA expression levels were compared with those of the 
unstimulated control.  Relative expression levels of ADAMTS9 mRNA were 
determined by quantitative real-time RT-PCR. Data are mean value ± SD of three 
independent experiments.  Note that the time-dependent induction pattern of 
ADAMTS9 mRNA expression by IL-1 in chondrocytes was similar to that of 
ADAMTS9 mRNA expression in OUMS-27 cells.  * Indicates P <0.05 compared to 
unstimulated cells.
Figure 3.   (A) Upper panel: Northern blot analysis of ADAMTS9 mRNA expression 
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in IL-1-stimulated OUMS-27 cells. A single band of ADAMTS9 mRNA is detected at 
the expected size.   Middle panel: Northern blot analysis of ADAMTS5 mRNA 
expression in IL-1-stimulated OUMS-27 cells. A single band of ADAMTS5 mRNA is 
faintly detected at the expected size.   Lower panel: Signals for 28S rRNA served as 
an internal control for each sample. (B) Western blot analysis for ADAMTS9 in 
IL-1-stimulated OUMS-27 cells. Cells were treated for 0 - 48 hr in serum-free 
DMEM in the absence (0) or presence of recombinant human IL-1 at 10ng/ml. 
ADAMTS9 protein (approximately 180kDa) is indicated (arrow).  The lower bands 
around 75 kDa and 100kDa are considered to be non-specific bands.  Note that 
ADAMTS9 protein also showed a peak at 6 hr after IL-1 stimulation. actin western 
blot was used to evaluate protein loading (C) Dose-dependent induction of ADAMTS9 
mRNA by IL-1. OUMS-27 cells were cultured in the presence of various 
concentrations of IL-1 (0, 10, 50 or 100 ng/ml) for 6 hr, and ADAMTS9 mRNA 
expression levels were compared with that of the unstimulated control. Relative 
expression levels of ADAMTS9 mRNA were determined by quantitative real-time 
RT-PCR. (D) Induction of ADAMTS9 mRNA by TNF- stimulation.  OUMS-27 
cells were cultured in the presence of TNF- (5 or 50 ng/ml) for 6 hr, and ADAMTS9 
mRNA expression levels were compared with that of the unstimulated control.  
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Relative expression levels of ADAMTS9 mRNA were determined by quantitative 
real-time RT-PCR. 
Figure 4.   (A) Synergistic induction of ADAMTS9 mRNA expression in OUMS-27
cells by the combination of IL-1 and TNF-. Medium was replaced with serum-free 
DMEM supplemented with recombinant human IL-1 (10 ng/ml), TNF- (10 ng/ml), or 
both cytokines for 6 hr. Relative ADAMTS9 mRNA expression levels are compared 
with those of unstimulated control cells by quantitative real-time RT-PCR analysis. 
Data are expressed as the mean ± SD of three independent experiments. (B) 
Synergistic induction of ADAMTS9 mRNA expression in chondrocytes by the 
combination of IL-1 and TNF-.   Human chondrocytes or human skin fibroblasts 
were cultured in the presence of recombinant human IL-1 (10 ng/ml), TNF- (10
ng/ml) or both cytokines for 6 hr, and ADAMTS9 mRNA expression levels are 
compared.  Relative expression levels of ADAMTS9 mRNA were determined by 
quantitative real-time RT-PCR. Data are expressed as the mean ±SD of three 
independent experiments. 
Figure 5. (A) Time-dependent phosphorylation of p38 and p44/42 MAP kinases
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in OUMS-27 cells after stimulation with IL-1.  Total protein extracts were subjected 
to PAGE and Western blot analysis was performed with phospho-p38 and
phospho-p44/42 antibodies as well as with antibodies to total with phospho-p38 and
phospho-p44/42.  (B) SB203580, a p38 MAPK inhibitor, attenuates the IL-1-induced 
ADAMTS9 mRNA expression level.  OUMS-27 cells cultured in serum-free medium 
were pretreated with SB203580 for 30 min, then stimulated with IL-1 for 6 hr.   The 
expression levels of ADAMTS9 mRNA were measured by quantitative real-time PCR 
analysis. (C) PD98059, a p44/p42 MAPK inhibitor, attenuates the IL-1-induced 
ADAMTS9 mRNA expression level.  OUMS-27 cells cultured in serum-free medium 
were pretreated with SB203580 for 30 min, then stimulated with IL-1 for 6 hr. 
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